Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 06, 2019

SELL
$3.0 - $7.58 $1,653 - $4,176
-551 Closed
0 $0
Q2 2019

Aug 07, 2019

BUY
$7.09 - $21.9 $1,311 - $4,051
185 Added 50.55%
551 $4,000
Q1 2019

May 07, 2019

BUY
$16.83 - $23.75 $3,079 - $4,346
183 Added 100.0%
366 $6,000
Q4 2018

Feb 08, 2019

BUY
$20.21 - $32.9 $3,698 - $6,020
183 New
183 $4,000

Others Institutions Holding KZR

About Kezar Life Sciences, Inc.


  • Ticker KZR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,369,504
  • Market Cap $446M
  • Description
  • Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...
More about KZR
Track This Portfolio

Track Tortoise Investment Management, LLC Portfolio

Follow Tortoise Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tortoise Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tortoise Investment Management, LLC with notifications on news.